BML Capital Management, LLC Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0001616824

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q2 2025 · 24 positions · Total reported value $132.18M · Top-10 concentration 86.7% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 38.1% · 3 new · 4 cut · 1 exited

Active Share (vs S&P 500): 99.2% · vs QQQ: 99.3% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): +2.1% · vs SPY -0.0% · Prev Value $176.05M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -15.2% · vs SPY -17.3% · Latest Value $187.62M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q2 2025 13F filing, BML Capital Management, LLC disclosed 24 equity positions with a combined reported value of $132.18M. The filing implies a focused portfolio: its ten largest positions account for 86.7% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2025 were AVIR ($27.40M), THRD ($20.77M), ACRS ($20.23M). By sector, the heaviest allocations are Health Care 60.6%, Industrials 2.2%. Versus the prior quarter, allocation shifted toward Industrials (+1.1pp), Other (+0.6pp) and away from Health Care (-1.7pp).

Versus the prior quarter, BML Capital Management, LLC opened 3 new positions, trimmed 4 and fully exited 1, a turnover rate of 38.1% of positions. The portfolio's overlap with the prior quarter was 79% of names.

The largest new positions opened in Q2 2025 were TSLA ($1.65M), CRVS ($475.06K).

Of the 1 positions fully exited versus the prior quarter, the largest were ANTX ($7.82M), WHWK ($3.36M), SAGE ($1.07M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2025)

  • TSLA TESLA INC · $1.65M
  • CRVS CORVUS PHARMACEUTICALS INC · $475.06K

Fully Exited (vs previous quarter)

  • ANTX AN2 THERAPEUTICS INC · prev qtr: $7.82M
  • WHWK WHITEHAWK THERAPEUTICS INC · prev qtr: $3.36M
  • SAGE SAGE THERAPEUTICS INC · prev qtr: $1.07M
  • NXTC NEXTCURE INC · prev qtr: $131.38K

Insider Transactions (Form 4)

Latest BML Capital Management, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

BML Capital Management, LLC files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 18 positions worth $176.05M in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Portfolio Structure

  • 18 positions · $176.05M reported value (Q2 2026)
  • Top 10 holdings = 93.3% of reported value
  • Largest position: ACRS (ACLARIS THERAPEUTICS INC) at 36.0%
  • Average position size: $9.78M

Sector Tilt

  • Health Care 80.1%
  • Consumer Discretionary 13.3%
  • Consumer Staples 6.2%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 3 new, 4 added, 3 reduced, 1 exited
  • 8 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 60.6%
Other 37.2%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 7.61M $27.40M 20.73%
20.73%
Hold
2 3.82M $20.77M 15.71%
15.71%
Hold
3 14.25M $20.23M 15.31%
15.31%
Hold
4 534.90K $11.14M 8.43%
8.43%
Add
5 4.22M $7.18M 5.43%
5.43%
Hold
6 3.08M $6.94M 5.25%
5.25%
Add
7 3.06M $6.57M 4.97%
4.97%
Add
8 4.03M $5.40M 4.09%
4.09%
Add
9 5.00M $5.30M 4.01%
4.01%
Add
10 1.21M $3.63M 2.75%
2.75%
Add
11 635.18K $2.91M 2.20%
2.20%
Add
12 1.97M $2.60M 1.97%
1.97%
Add
13 1.14M $2.20M 1.67%
1.67%
Hold
14 5.89M $2.16M 1.64%
1.64%
Hold
15 1.82M $1.79M 1.35%
1.35%
Reduce
16 200 $1.65M 1.25%
1.25%
New
17 220.41K $1.27M 0.96%
0.96%
Hold
18 3.23M $975.66K 0.74%
0.74%
Add
19 209.81K $608.27K 0.46%
0.46%
Reduce
20 118.77K $475.06K 0.36%
0.36%
New
21 1.10M $396.12K 0.30%
0.30%
Hold
22 150.00K $300.00K 0.23%
0.23%
Hold
23 91.91K $182.91K 0.14%
0.14%
Add
24 174.65K $92.58K 0.07%
0.07%
Hold

FAQ

What did BML Capital Management, LLC buy in 2025-Q2?

In its 2025-Q2 13F filing, BML Capital Management, LLC reported 24 equity positions worth $132.18M in aggregate; its largest disclosed positions were AVIR ($27.40M), THRD ($20.77M), ACRS ($20.23M).

How large is BML Capital Management, LLC's portfolio?

BML Capital Management, LLC reported $132.18M of long equity holdings across 24 positions as of 2025-Q2. Top-10 holdings account for 86.7% of reported value.

What is BML Capital Management, LLC's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/bml-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →